- Type / Class
- Equity / Common Stock
- Shares outstanding
- 49,862,069
- Total 13F shares
- 45,490,986
- Share change
- +1,574,423
- Total reported value
- $657,609,131
- Price per share
- $14.46
- Number of holders
- 91
- Value change
- +$17,178,106
- Number of buys
- 63
- Number of sells
- 24
Quarterly Holders Quick Answers
What is CUSIP 43157M102?
CUSIP 43157M102 identifies HLVX - HilleVax, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 43157M102:
Top shareholders of HLVX - HilleVax, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of HilleVax, Inc. - Common Stock (HLVX) as of Q2 2024
As of 30 Jun 2024,
HilleVax, Inc. - Common Stock (HLVX) was held by
91 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,490,986 shares.
The largest 10 holders included
Frazier Life Sciences Management, L.P., TAKEDA PHARMACEUTICAL CO LTD, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), T. Rowe Price Investment Management, Inc., BlackRock Inc., FRANKLIN RESOURCES INC, Carlyle Group Inc., Deep Track Capital, LP, VANGUARD GROUP INC, and Catalys Pacific, LLC.
This page lists
92
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
80
Q2 2024 holders
91
Holder diff
11
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.